CERC - European Cardiovascular Research Center
Founded by a group of physicians, CERC has a wide experience in clinical research. Their renown and expertise in this field have enabled them to generate optimal interaction with their industrial partners and other medical research teams focusing on the development of innovative techniques, concepts and treatments.
They provide unparalleled guidance and expert support in a broad range of clinical trials dedicated to the assessment of interventional coronary and peripheral revascularisation, structural and valvular heart disease treatments and adjunctive pharmacology.
Its objectives are to underpin European clinical trials and academic leadership, act as a global CRO and support young scientific leaders.
The CERC’s industrial partners attach great importance to finding cost-effective models which do not compromise quality.
Learn more: www.cerc-europe.org
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
2 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
November 30, 2023
📅 5th December – 1:30pm to 2:15pm (CET) 📍 On line via Gotowebinar 💶 Free but mandatory registration Register In Clinical Research, difficulties in recruiting subjects are one of the main causes of premature termination of clinical trials. Between 20 to 30% of clinical trials are affected by inclusion delays and more than 1 out of […]
November 30, 2023
Applied Clinical Trials Online Site and project management teams play major roles in risk-management and monitoring performance. As the modernization of clinical research through digital and decentralized solutions continues to take research into local communities, reduce patient and site burden, and increase diversity, it will lead to new ways of working for project delivery teams. […]
November 30, 2023
Applied Clinical Trials Online Study aims to find ways industry gets involved in the most influential clinical trials, and how transparent these trials are. In a study published earlier this month by JAMA, the authors aimed to discover how the pharmaceutical industry gets involved in the most influential modern clinical trials and how they fare […]